The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)

NCT03197870 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

167

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonproliferative Diabetic Retinopathy

Interventions

DRUG: AKB-9778
DRUG: Placebo

Sponsor

EyePoint Pharmaceuticals, Inc.